NCT05638295 2026-04-22
Testing the Use of AMG 510 (Sotorasib) and Panitumumab as a Targeted Treatment for KRAS G12C Mutant Solid Tumor Cancers (A ComboMATCH Treatment Trial)
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Astellas Pharma Inc
Duke University
Erasca, Inc.
Erasca, Inc.
Federation Francophone de Cancerologie Digestive